Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Quoin Pharmaceuticals Ltd. ADR

Start price
Target price
Perf. (%)
€13.88
25.01.22
€25.00
25.01.23
9.01%
05.02.22

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
buy
Bayer AG

Start price
Target price
Perf. (%)
€50.08
24.01.22
-
24.01.26
-47.43%
11.03.24

Could be worthwhile Investment >10% per year
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Teladoc Health Inc

Start price
Target price
Perf. (%)
€60.46
24.01.22
€52.00
24.01.23
5.86%
30.01.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€407.05
24.01.22
€418.00
24.01.23
10.66%
25.01.23

Could be worthwhile Investment >10% per year
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.17
24.01.22
-
24.01.23
116.40%
25.01.23

Could be worthwhile Investment >10% per year
buy
Varex Imaging Corp

Start price
Target price
Perf. (%)
€24.00
24.01.22
€28.00
24.01.23
-20.42%
25.01.23

Could be worthwhile Investment >10% per year
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€12.78
24.01.22
-
24.01.23
22.85%
07.02.22

Could be worthwhile Investment >10% per year
Very high cyclical dependencies
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€2.76
23.01.22
-
23.01.23
-8.12%
06.02.22

Risky Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€14.52
23.01.22
-
23.01.23
7.06%
06.02.22

Could be worthwhile Investment >10% per year
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€12.00
23.01.22
-
23.01.23
-6.50%
06.02.22

Could be very worthwhile Investment >20% year
buy
Geron Corp.

Start price
Target price
Perf. (%)
€0.89
23.01.22
€5.00
23.01.24
129.79%
17.09.23

Very Future proof/growth oriented business model
Strong uniques
Could be very worthwhile Investment >20% year
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.30
23.01.22
-
23.01.23
15.82%
06.02.22

Risky Investment
buy
Valneva SE

Start price
Target price
Perf. (%)
€15.90
23.01.22
-
23.01.23
-5.47%
06.02.22

Could be very worthwhile Investment >20% year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€74.55
23.01.22
-
23.01.23
7.12%
06.02.22

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€6.43
23.01.22
-
23.01.23
7.21%
06.02.22

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€213.80
18.01.22
€350.00
18.01.23
47.33%
23.09.22

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.00
17.01.22
-
17.01.23
-44.67%
22.01.22

Risky Investment
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€24.44
14.01.22
-
14.01.23
-10.19%
22.01.22

Risky Investment
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.62
14.01.22
-
14.01.23
-12.67%
22.01.22

Could be worthwhile Investment >10% per year
buy
Immuron

Start price
Target price
Perf. (%)
€2.96
14.01.22
€0.000
14.01.23
18.92%
28.01.22

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Undervalued
Low dividend yield expected
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€12.17
13.01.22
-
13.01.23
-7.52%
22.01.22

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€37.69
13.01.22
-
13.01.23
-12.15%
23.01.22

Could be very worthwhile Investment >20% year
buy
IVERIC bio Inc.

Start price
Target price
Perf. (%)
€11.23
12.01.22
€18.00
31.12.23
35.92%
07.09.22

Could be very worthwhile Investment >20% year
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€90.00
12.01.22
-
12.01.23
-44.82%
13.01.23